Ibrance 125 MG capsule 21S
Ended Awarded Last action
- Contract number
- SPE2DR26FY8YP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,555
Award facts
- Contract value 100% obligated
- $8,555.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 28, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $8,555.21 to AmerisourceBergen Drug Corp for the supply of Ibrance 125 mg capsules (21-count packaging). The award, which is expected to be completed by February 19, 2026, carries a firm fixed-price structure with no set-aside designation, indicating the vendor competed on a full and open basis. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance for this contract. This delivery order is a child contract executed under a larger Indefinite Delivery Contract (IDC) between the parent company Cencora, Inc. (doing business as AmerisourceBergen) and DLA Troop Support Medical, which is valued at up to $999,999,999.00 and extends through December 2031.
The IDC vehicle under which this award was issued serves as a comprehensive global pharmaceutical support contract designed to supply military healthcare programs with an extensive range of pharmaceutical products and medical supplies. Ibrance is an oncology medication used in cancer treatment, consistent with the broad therapeutic categories supported through the parent contract, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical commodities. This delivery order represents a routine fulfillment of the company's obligation to supply critical pharmaceutical products to support Department of Defense healthcare operations and military treatment facilities.
Quick answers
Who was awarded contract SPE2DR26FY8YP?
SPE2DR26FY8YP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FY8YP worth?
The government has obligated $8,555 on SPE2DR26FY8YP.
Is contract SPE2DR26FY8YP an order under another contract?
Yes. SPE2DR26FY8YP is a delivery order under SPE2DR25D1007, an indefinite delivery contract.
Was contract SPE2DR26FY8YP competed?
The extent of competition for SPE2DR26FY8YP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award